Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

被引:36
|
作者
Vita, Antonio [1 ,2 ]
Barlati, Stefano [1 ,2 ]
Ceraso, Anna [1 ]
Deste, Giacomo [2 ]
Nibbio, Gabriele [1 ]
Wykes, Til [3 ,4 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy
[2] ASST Spedali Civili Brescia, Dept Mental Hlth & Addict Serv, Brescia, Italy
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[4] Maudsley Hosp & Inst Psychiat, South London & Maudsley NHS Fdn Trust, Denmark Hill, London, England
关键词
Acceptability; cognitive remediation; drop-out; meta-analysis; schizophrenia; systematic review; PSYCHOSOCIAL TREATMENT; TRAINING-PROGRAM; LOW-SUPPORT; THERAPY; ADHERENCE; EFFICACY; OUTCOMES; IMPACT; BLIND; RATES;
D O I
10.1017/S0033291722000319
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Acceptability is an important factor for predicting intervention use and potential treatment outcomes in psychosocial interventions. Cognitive remediation (CR) improves cognition and functioning in people with a diagnosis of schizophrenia, but its acceptability, and the impact of participants and treatment characteristics, remain to be investigated. Few studies provide a direct measure of acceptability, but treatment drop-out rates are often available and represent a valid surrogate. Method The systematic search conducted for the most comprehensive CR outcomes database for schizophrenia was updated in December 2020. Eligible studies were randomized clinical trials comparing CR with any other control condition in patients diagnosed with schizophrenia spectrum disorders and that also reported drop-out in treatment and control arms separately. Acceptability was measured as odd-ratios (OR) of drop-out. Results Of 2119 identified reports, 151 studies, reporting 169 comparisons between CR and control interventions with 10 477 participants were included in the analyses. The overall rate of drop-out was 16.58% for CR programs and 15.21% for control conditions. In the meta-analysis, no difference emerged between CR interventions and controls [OR 1.10, 95% confidence interval (CI) 0.96-1.25, p = 0.177]. Factors improving acceptability were: inpatient only recruitment, participants with fewer years of education and lower premorbid IQ, the presence of all CR core elements, and the presence of techniques to transfer cognitive gains into real-world functioning. Conclusions CR for people diagnosed with schizophrenia is effective and has a good acceptability profile, similar to that of other evidence-based psychosocial interventions.
引用
收藏
页码:3661 / 3671
页数:11
相关论文
共 50 条
  • [21] Recruitment and adherence of randomized controlled trials for mild cognitive impairment: A systematic review and meta-analysis
    Xu, Zijun
    Sun, Wen
    Zhang, Dexing
    Wong, Samuel Yeungshan
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 35 (10) : 1141 - 1150
  • [22] Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials
    Cui, Chendi
    Birru, Rahel L.
    Snitz, Beth E.
    Ihara, Masafumi
    Kakuta, Chikage
    Lopresti, Brian J.
    Aizenstein, Howard J.
    Lopez, Oscar L.
    Mathis, Chester A.
    Miyamoto, Yoshihiro
    Kuller, Lewis H.
    Sekikawa, Akira
    NUTRITION REVIEWS, 2020, 78 (02) : 134 - 144
  • [23] Efficacy of cognitive and functional remediation in bipolar disorder: A meta-analysis of randomized controlled trials
    Samame, Cecilia
    Aprahamian, Ivan
    BIPOLAR DISORDERS, 2023, 25 : 108 - 108
  • [24] Preoperative cognitive training improves postoperative cognitive function: a meta-analysis and systematic review of randomized controlled trials
    Zhao, Li
    Guo, Yiping
    Zhou, Xuelei
    Mao, Wei
    Li, Linji
    FRONTIERS IN NEUROLOGY, 2024, 14
  • [25] Efficacy and acceptability of vitamin D supplements for depressed patients: A systematic review and meta-analysis of randomized controlled trials
    Srifuengfung, Maytinee
    Srifuengfung, Somporn
    Pummangura, Chalermsri
    Pattanaseri, Keerati
    Oon-arom, Awirut
    Srisurapanont, Manit
    NUTRITION, 2023, 108
  • [26] Efficacy, acceptability and safety of guided imagery/hypnosis in fibromyalgia - A systematic review and meta-analysis of randomized controlled trials
    Zech, N.
    Hansen, E.
    Bernardy, K.
    Haeuser, W.
    EUROPEAN JOURNAL OF PAIN, 2017, 21 (02) : 217 - 227
  • [27] Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials
    Oya, Kazuto
    Kishi, Taro
    Iwata, Nakao
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (05) : 483 - 491
  • [28] Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trials
    Irene Bighelli
    Sofia Wallis
    Cornelia Reitmeir
    Felicitas Schwermann
    Nurul Husna Salahuddin
    Stefan Leucht
    European Archives of Psychiatry and Clinical Neuroscience, 2023, 273 : 779 - 810
  • [29] The effects of mindful exercise on cognition in patients with schizophrenia: A systematic review and meta-analysis of randomized controlled trials
    Chen, Chyi-Rong
    Lee, Yi-Wen
    Chen, Tzu-Ting
    Hsu, Chih-Wei
    Huang, Yu-Chi
    Lin, Pao-Yen
    Lin, Keh-chung
    SCHIZOPHRENIA RESEARCH, 2024, 271 : 237 - 245
  • [30] Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trials
    Osugo, Martin
    Whitehurst, Thomas
    Shatalina, Ekaterina
    Townsend, Leigh
    O'Brien, Oisin
    Mak, Tsz Lun Allenis
    McCutcheon, Robert
    Howes, Oliver
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2022, 135